Roche and GlaxoSmithKline have launched IV ibandronic acid [Bonviva] for postmenopausal osteoporosis in the UK

Author:  

Publisher: Adis International

ISSN: 1173-8324

Source: Inpharma, Vol.1, Iss.1536, 2006-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract